ArticleJournal of nanobiotechnology2026

MXene-based CRISPR/Cas9 nanoplatform targeting FABP5 for ROS amplification and synergistic photothermal/photodynamic therapy of cervical cancer.

Chang-Qing Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.